Phase 1 Study of Lapatinib in Combination with Radiation Therapy in Patients with Brain Metastases from HER2-Positive Breast Cancer
Study on the Effects of an Investigational Treatment for Condition X
Not Recruiting
18 years - 100 years
All
Phase
N/A
Brief description of study.
No Description Available
Detailed description of study
No Description Available
Eligibility of study
You may be eligible for this study if you meet the following criteria:
Conditions:Breast Cancer
Age:
18 years - 100 years
Gender: All
Who can participate: Eligible participants are individuals aged 18 to 65 years who have been diagnosed with Condition X. Key eligibility criteria include no prior treatment for Condition X and no significant health conditions that could interfere with the study.
Study details: Participants will receive either the investigational treatment or a placebo. The study involves regular monitoring of health indicators and completion of health questionnaires.
Updated on
19 Feb 2024.
Study ID: 1011003086 (0711-07)
Interested in the study?
Select a study center that’s convenient for you, and get in touch with the study team.
